Currently, PTP inhibitors have been explored in clinical trials [105,106,107,108], such as one trial examining the role of inhibitors of PTP1B in metabolic diseases [109], but inhibitors of PTPRJ have not yet been identified, which may be an indication for future research. This evidence concerns the gene PTPRJ and metabolic disease.